SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-138898
Filing Date
2013-04-03
Accepted
2013-04-02 17:53:03
Documents
5
Period of Report
2013-05-17
Effectiveness Date
2013-04-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d514736ddef14a.htm DEF 14A 572048
2 GRAPHIC g514736g71o10.jpg GRAPHIC 20657
3 GRAPHIC g514736g92z65.jpg GRAPHIC 7243
4 GRAPHIC g514736pic1.jpg GRAPHIC 150259
5 GRAPHIC g514736pic2.jpg GRAPHIC 103741
  Complete submission text file 0001193125-13-138898.txt   962110
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 13736999
SIC: 2834 Pharmaceutical Preparations